Alto Neuroscience, Inc. (ANRO)
21.22
-0.32
(-1.49%)
USD |
NYSE |
May 22, 16:00
21.21
-0.01
(-0.05%)
After-Hours: 20:00
Alto Neuroscience Shareholders Equity (Quarterly) : 243.37M for March 31, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Johnson & Johnson | 81.19B |
| Eli Lilly & Co. | 31.20B |
| NRX Pharmaceuticals, Inc. | -13.82M |
| LB Pharmaceuticals, Inc. | 378.69M |
| ANI Pharmaceuticals, Inc. | 562.30M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 276.26M |
| Total Liabilities (Quarterly) | 32.89M |
| Debt to Equity Ratio | 0.0954 |
| Current Ratio | 20.52 |
| Net Debt Paydown Yield | -0.16% |